Probing the mechanism of drug/lipid membrane interactions using Biacore

Analytical Biochemistry

Volumn 328, Issue 2, 2004, Pages 233-243

  Abdiche, Yasmina N ^a   Myszka, David G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Affinity; Binding; Permeability; Phospholipidosis; Plasmon

Indexed keywords

BINDING ENERGY; BIOASSAY; DRUG DOSAGE; DRUG INTERACTIONS; MECHANICAL PERMEABILITY; PLASMONS; SURFACE PLASMON RESONANCE;

AFFINITY; ARTIFICIAL MEMBRANES; BINDING; MEMBRANE INTERACTIONS; PHOSPHOLIPIDOSIS; RETENTION MEASUREMENT; STRUCTURAL DIFFERENCES; SURFACE PLASMON RESONANCE BIOSENSOR;

DRUG DELIVERY;

7 DEHYDROCHOLESTEROL; AMIDE; AMITRIPTYLINE; AMPHOPHILE; CATION; CHLORPROMAZINE; CINCHOCAINE; CLOMIPRAMINE; CYPROTERONE; DESIPRAMINE; DEXAMETHASONE; ETHOXZOLAMIDE; FLUTAMIDE; GENISTEIN; IMIPRAMINE; LIPID; LIPOSOME; MESULERGINE; NAFOXIDINE; NAFTOPIDIL; NORCLOMIPRAMINE; NORDIHYDROGUAIARETIC ACID; NORTRIPTYLINE; PERPHENAZINE; PROPRANOLOL; RALOXIFENE; TAMOXIFEN; THIORIDAZINE; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; ARTIFICIAL MEMBRANE; BINDING AFFINITY; BIOSENSOR; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISSOCIATION; DRUG BINDING; DRUG CLASSIFICATION; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; IN VIVO STUDY; LIPID MEMBRANE; LIPIDOSIS; MEASUREMENT; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; SURFACE PROPERTY;

EID: 2142767300     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.01.018     Document Type: Article

References (8)

1. Baird C.L., Courtenay E.S., Myszka D.G. Surface plasmon resonance characterization of drug/liposome interactions. Anal. Biochem. 310:2002;93-99
2. Kansy M., Senner F., Gubernator K. Physicochemical high throughput screening: parallel artificial membrane assay in the description of passive absorption processes. J. Med. Chem. 41:1998;1007-1010
3. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51:1999;691-744
4. Scuntaro I., Kientsch U., Wiesmann U.N., Honegger U.E. Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Br. J. Pharmacol. 119:1996;829-834
5. Lullmann H., Plosch H., Ziegler A. Ca replacement by cationic amphiphilic drugs from lipid monolayers. Biochem. Pharmacol. 29:1980;2969-2974
6. Caron G., Steyaert G., Pagliara A., Reymond F., Crivori P., Gaillard P., Carrupt P.-A., Avdeef A., Comer J., Box K.J., Girault H.H., Testa B. Structure-lipophilicity relationships of neutral and protonated-blockers, part I: intra and intermolecular effects in isotropic solvent systems. Helvet. Chim. Acta. 82:1999;1211-1222
7. Cooper M.A., Hansson A., Löfås S., Williams D.H. A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal. Biochem. 277:2000;196-205
8. Erb E.M., Chen X., Allen S., Roberts C.J., Tendler S.J., Davies M.C., Forsen S. Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal. Biochem. 280:2000;29-35